Cargando…
Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529244/ https://www.ncbi.nlm.nih.gov/pubmed/26252715 http://dx.doi.org/10.1371/journal.pone.0135547 |
_version_ | 1782384769475018752 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4529244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45292442015-08-12 Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients PLoS One Correction Public Library of Science 2015-08-07 /pmc/articles/PMC4529244/ /pubmed/26252715 http://dx.doi.org/10.1371/journal.pone.0135547 Text en © 2015 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Correction Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title | Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title_full | Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title_fullStr | Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title_full_unstemmed | Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title_short | Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients |
title_sort | correction: a lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat hiv/hepatitis c coinfected patients |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529244/ https://www.ncbi.nlm.nih.gov/pubmed/26252715 http://dx.doi.org/10.1371/journal.pone.0135547 |
work_keys_str_mv | AT correctionaleadinwithsilibininpriortotripletherapytranslatesintofavorabletreatmentoutcomesindifficulttotreathivhepatitisccoinfectedpatients |